Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$396,501,432
+$108,841,138 QoQ
Shares Held
8,270,785
+5.7% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#11
of 1,341 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. NVO ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in NVO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $396,501,432 | 8,270,785 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $287,660,294 | 7,827,491 | Shares | Defined | 2026-05-14 | |
| 2025-03-31 | $745,646 | 10,738 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,169,991 | 48,477 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $8,018,451 | 450,803 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $56,510,480 | 395,898 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $62,174,174 | 601,007 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $116,709,031 | 1,283,363 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $50,368,131 | 311,241 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $15,470,158 | 97,211 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,450,844 | 10,720 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,723,784 | 27,339 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $196,380,889 | 1,762,370 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $142,822,737 | 1,286,112 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $103,234,880 | 921,740 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $37,245,735 | 387,936 | Shares | Defined | 2021-11-12 | |
| 2020-12-31 | $46,543,988 | 666,342 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $86,512,210 | 1,246,035 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $200,244,191 | 3,058,097 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $233,876,157 | 3,884,986 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||